Pharmaceutical giant Pfizer is expanding its not-for-profit products, widening its existing initiative with the aim of lowering health inequities.

Verily, the life sciences subsidiary of Google parent company Alphabet, is laying off 15% of its workforce just months after raising $1 billion in a funding round.

Medtronic says the spinoff is an opportunity to better position both entities and create value.

The U.S. Food and Drug Administration (FDA) has launched a new pilot program that aims to streamline medical device development, increase predictability and reduce the time from concept to commercialization.

Verily, a life science company that was formerly a division of Google X, has raised $1 billion in a funding round led by Alphabet, parent company to Google.

“With increasing global rates of Lyme disease, providing a new option for people to help protect themselves from the disease is more important than ever,” says Annaliesa Anderson, PhD, senior vice president and head of vaccine research & development at Pfizer.

Surgeons at NYU Langone Health successfully transplanted two genetically engineered pigs hearts into recently deceased humans in June and July.

A universal vaccine would offer broader and longer-lasting protection against seasonal flu viruses and new flu viruses.